Details for 2011851933
Up to date per 12.04.2026
Actions
Details for 2011851933
Granted/Registered
European Patent
30.10.2013 A
24.01.2018 B1
21.12.2010
US
97473910
31.08.2011
US
201161529682 P
C07K 16/28 20060101AFI20150203BHEP
Owner
NOVARTIS AGLichtstrasse 354056 BaselCH
Oklahoma Medical Research Foundation 825 N.E. 13th Street Oklahoma City, OK 73104US
Representative
Representative
Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT
Inventor
ROLLINS, Scott5501 White Fences Oklahoma City, OK 73131US
ALVAREZ, Richard4817 Clipper Xing Edmond, OK 73013-9007US
ROTHER, Russell10325 Forest Meadow Drive Oklahoma City, OK 73151US
KAWAR, Ziad, S.333 N W. 5th Street, Apt. 1802 Oklahoma City, OK 73120US
MCEVER, Rodger, P.1716 Guilford Lane Oklahoma City, OK 73120US
Information about Fees